Walleye Trading
PCRX icon

Walleye Trading’s Pacira BioSciences PCRX Stock Holding History

Walleye Trading’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,300
Closed -$155K – 4765
2024
Q1 		$155K Sell
5,300
-10,800
-67% -$332K ﹤0.01% 3568
2023
Q4 		$543K Buy
16,100
+9,300
+137% +$272K ﹤0.01% 3006
2023
Q3 		$209K Buy
+6,800
New +$245K ﹤0.01% 3574
2022
Q4 		– Sell
-300
Closed -$16K – 5288
2022
Q3 		$16K Hold
300
– – ﹤0.01% 4463
2022
Q2 		$17K Sell
300
-1,100
-79% -$72.1K ﹤0.01% 4553
2022
Q1 		$107K Sell
1,400
-100
-7% -$6.67K ﹤0.01% 4203
2021
Q4 		$90K Buy
+1,500
New +$82.7K ﹤0.01% 4433
2021
Q3 		– Sell
-10,500
Closed -$637K – 5580
2021
Q2 		$637K Buy
+10,500
New +$665K ﹤0.01% 2629
2020
Q1 		– Sell
-9,500
Closed -$430K – 4409
2019
Q4 		$430K Buy
+9,500
New +$403K ﹤0.01% 2537
2019
Q3 		– Sell
-800
Closed -$35K – 4331
2019
Q2 		$35K Buy
+800
New +$34K ﹤0.01% 3644
2019
Q1 		– Sell
-13,200
Closed -$568K – 4632
2018
Q4 		$568K Sell
13,200
-32,400
-71% -$1.51M ﹤0.01% 2347
2018
Q3 		$2.24M Buy
+45,600
New +$1.97M 0.01% 1212
2017
Q3 		– Sell
-2,400
Closed -$115 – 4481
2017
Q2 		$115 Sell
2,400
-600
-20% -$27.8K ﹤0.01% 3473
2017
Q1 		$137 Buy
3,000
+2,900
+2,900% +$125K ﹤0.01% 3211
2016
Q4 		$3K Buy
+100
New +$3.34K ﹤0.01% 4526

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Walleye Trading's PCRX Position: Q3 2024 in Review

Walleye Trading sold out of Pacira BioSciences (PCRX) in Q3 2024, closing a stake of 35,873 shares — an estimated $1.03M sold.

Walleye Trading first reported a position in PCRX in Q4 2015 and held it in 14 quarters. The position peaked at $1.03M in Q2 2024. 239 funds tracked by Wall St. Rank hold PCRX as of Q3 2024.

  • Walleye Trading reported no remaining Pacira BioSciences position as of Q3 2024 after selling out during the quarter.
  • Walleye Trading sold 35,873 Pacira BioSciences shares in Q3 2024, an estimated $1.03M.
  • Walleye Trading first reported a position in Pacira BioSciences in Q4 2015 and held it in 14 quarters.
  • Walleye Trading's Pacira BioSciences position peaked at $1.03M in Q2 2024.
  • 239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2024.

Based on Walleye Trading's 13F filing for Q3 2024, filed 14 Nov 2024.